Azilect and Drug administration error - a phase IV clinical study of FDA data

Summary:

Drug administration error is reported as a side effect among people who take Azilect (rasagiline mesylate), especially for people who are male, 30-39 old, have been taking the drug for 2 - 5 years also take Requip, and have Bladder disorder.

The phase IV clinical study analyzes which people have Drug administration error when taking Azilect. It is created by eHealthMe based on reports of 8,121 people who have side effects when taking Azilect from the FDA, and is updated regularly.

What is Azilect?

Azilect has active ingredients of rasagiline mesylate. It is often used in parkinson's disease. eHealthMe is studying from 8,622 Azilect users. Check the latest studies of Azilect.

What is Drug administration error?

Drug administration error is found to be associated with 1,013 drugs and 1,484 conditions by eHealthMe. Check the latest studies of Drug administration error.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

8,121 people reported to have side effects when taking Azilect.
Among them, 20 people (0.25%) have Drug administration error.

Could Azilect cause Drug administration error?

Among these 20 people:

How long have people been on Azilect when they have Drug administration error? *

What is the gender of people who have Drug administration error when taking Azilect? *

female: 50 %
male: 50 %

What is the age of people who have Drug administration error when taking Azilect? *

What are other drugs people take besides Azilect? *

What are other side effects people have besides Drug administration error? *

Feeling Abnormal: 9 people, 45.00%
Drug Ineffective: 8 people, 40.00%
Fall: 6 people, 30.00%
Tremor (trembling or shaking movements in one or more parts of your body): 6 people, 30.00%
Cough: 6 people, 30.00%
Dizziness: 6 people, 30.00%
Nausea (feeling of having an urge to vomit): 6 people, 30.00%
Fatigue (feeling of tiredness): 6 people, 30.00%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 6 people, 30.00%
Pneumonia: 5 people, 25.00%

What are the existing conditions these people have? *

Sleep Disorder: 1 person, 5.00%
Pain: 1 person, 5.00%
Osteoporosis (bones weak and more likely to break): 1 person, 5.00%
Localised Infection (infection at the single location): 1 person, 5.00%
Hallucinations (sensations that appear real but are created by your mind): 1 person, 5.00%
Diabetes: 1 person, 5.00%
Depression: 1 person, 5.00%
Dementia (madness): 1 person, 5.00%
Delusion (a false belief or opinion): 1 person, 5.00%
Bladder Disorder: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Azilect and have Drug administration error?

- Check whether Drug administration error is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Azilect:

Azilect (8,622 reports)

Browse all side effects of Azilect:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drug administration error:

Drug administration error (1,013 drugs)

Browse all the conditions that are associated with Drug administration error:

Drug administration error (1,484 conditions)

Related publications that referenced our studies

Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .
Hipoglisemi RB, "Rasagiline-Induced Hypoglycemia", , 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on rasagiline mesylate (the active ingredients of Azilect) and Azilect (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.